Last updated on November 2005

Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration


Brief description of study

The purpose of this study is to confirm the efficacy and safety of rostaporfin (PHOTREX) photodynamic therapy (PDT) in the treatment of classic and occult subfoveal choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD).

Clinical Study Identifier: NCT00157976

Find a site near you

Start Over

Multiple Investigators

Brno-Bohunice, Olomouc, Praha, Czech Republic
  Connect »

Multiple Investigators

Warsaw, Bydgoszcz, Lubin, Poland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.